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The purpose of this study was to develop a new approach to tailor crystal size based on the formation 
of acetaminophen encapsulated polymeric nanoparticles by nanoprecipitation (“diffusion-stranding” 
process) using a co-flow microfluidic device. The polymer additive is expected to reduce the 
nucleation rate [1], whereas the nanometer size range of the particles allows for efficient uptake by a 
variety of cell types without causing an embolism [2]. In this study, polycaprolactone (PCL) was 
chosen as a carrier for nanoparticle fabrication, because it is a biodegradable and bioresorbable 
polymer commonly used in pharmaceutical industry [3], while tetrahydrofuran (THF) was used as a 
water-miscible volatile solvent [4]. Nanoparticles were fabricated in a glass capillary device consisted 
of coaxial assembly of round and square capillaries glued onto the surface of a microscope slide. The 
organic phase containing 0.1 % (w/w) polymer and 0.02- 0.07 % (w/w) acetaminophen in THF was 
injected through the inner capillary tube with a tapered cross section culminated in a circular orifice. 
The water phase containing 0.1 % (w/w) Tween 80 (surfactant) was delivered co-currently through the 
outer square capillary. The organic phase formed a microscopic jet of controllable size in the aqueous 
phase and the particles were formed by counter-current diffusion of water and THF at the water-
organic phase interface. Due to transparent walls of the capillaries, the process was observed by a 
high-speed camera. Microfluidic devices with an orifice size of 200 µm were fabricated and the 
particle generation process for each orifice size was investigated using five different aqueous to 
organic phase ratios, Qaq/Qor (1.5, 3.0, 4.5, 7.0, and 10.0). The experimental set-up is depicted in Fig. 
1. The nanoparticles were produced with a mean size of 238−326 nm and a drug entrapment 
efficiency between 21.3 % and 77.5 %, depending on the acetaminophen content and Qaq/Qor value. 
 
 
Fig. 1: Schematic diagram of the experimental setup used in this work 
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